STM Pharma PRO srl Report issue

For profit Phase 2

Organization Overview

First Clinical Trial
2020
NCT04449133
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

STM Pharma PRO srl